Markes becomes licensed world commercial supplier of thin-film solid-phase microextraction (TF-SPME)

Markes International Ltd has entered into a licensing and supply agreement with JP Scientific Ltd, producer and patent holder of thin-film solid-phase microextraction (TF-SPME), allowing Markes to supply the novel sampling device worldwide for a wide range of applications. TF-SPME is a sampling technique that uses carbon mesh sheets impregnated with sorbent phase(s). It is [...]

SCIEX Joins Genedata’s Ready-to-Run Partner Program

FRAMINGHAM, Mass.--SCIEX, a global leader in life science analytical technologies, announced that it joined the Ready-to-Run Partner Program at Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D. This will help SCIEX and Genedata address increasing data analysis requirements, and support the incorporation of AI, machine learning, and automation in the industry. Ready-to-Run integrations [...]

Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution

PARIS -- Stilla Technologies, the provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director. These hires come at a time of [...]

GEDmatch Partners with Genomics Firm

SAN DIEGO, CA  — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance the customer experience for users of its website. “I am confident that we have found an ideal partner for [...]

Creoptix Appoints Line Stigen Raquet as Chief Executive Officer

Wädenswil/Zurich, Switzerland – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020. After seven years in the position, Matyas Vegh has decided to pursue new opportunities outside the company. “I am grateful to Matyas for his [...]

OGT develops transformative constitutional NGS panel

CytoSure NGS – Combining the benefits of microarrays and NGS in a single assay  Oxford, UK –  Oxford Gene Technology (OGT), A Sysmex Group Company, has developed a breakthrough targeted NGS panel for constitutional cytogenetics research. The new CytoSure™ NGS panel—launching early in 2020—will combine the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay. [...]

Large-scale population genomics project announced by Department of Health in Abu Dhabi, using PromethION

  Today, a new, large-scale population genomics project was announced by the Department of Health in Abu Dhabi, UAE.  The programme aims to improve the understanding of the genomics of individuals in the region as part of a personalised medicine initiative. The project is also exploring ways to deliver participants their own genomes as part [...]

IsoPlexis Announces “Cracking the IsoCode: Single Cell Functional Biomarkers Challenge”

RANFORD, Conn.  -- Isoplexis the leading single-cell functional proteomics company, has announced their "Cracking the IsoCode: Single Cell Functional Biomarkers Challenge", where researchers are invited to share next generation insights using single-cell functional proteomics for the opportunity to win a project on the IsoLight system at their institution. Applicants should submit an abstract up to 500 [...]

GenScript Releases Precision Mutant Library Services for Drug Development and Synthetic Biology

PISCATAWAY, N.J. and SAN DIEGO -- GenScript, the world's leading gene synthesis provider, announced today at the Antibody & Engineering Therapeutics meeting in San Diego the launch of its Precision Mutant Library Services for the drug development, industrial chemical and synthetic biology markets. The service overcomes the challenges of traditional library construction methods, saving researchers valuable screening time, expediting drug discovery and [...]

Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

New Funding Brings Total Amount Raised by the Company to $259.5 Million Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/FT. Paladin Capital Group led the round, bringing the total amount raised [...]

Access IBO on Knowledge Center